AN EXCITING OPPORTUNITY TO JOIN A COLLABORATIVE MULTIPLE SCLEROSIS RESEARCH PROJECT AT THE JOHN RADCLIFFE HOSPITAL, UNIVERSITY OF OXFORD
You are invited to apply to join Professor Lars Fugger and his team at the Oxford Centre for Neuroinflammation (OCNI), as part of the Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK. You will lead a collaborative research project led between Professor Lars Fugger, Dr Kate Attfield and Bristol Myers Squibb (Celgene), to explore and develop new treatment options for multiple sclerosis patients.
Multiple sclerosis (MS) is the most common, chronic disabling neurological condition in young adults, afflicting more than 2.5 million people worldwide. The unmet challenge to prevent disease progression in patients with multiple sclerosis (MS) indicates that current treatment options are constrained by our understanding of disease cause and the pathways or cell types that become engaged at both onset and throughout disease course.
As part of an exciting translational medicine research project, the successful candidate will use single-cell technologies and spatial transcriptomics to analyse patient samples, utilize in vivo model systems and perform functional genomics assays, to develop new treatment options for patients.
You must be highly motivated, creative and innovative. A background in human immunology or neuroimmunology is essential, as well as holding a relevant PhD/Dphil in neuroscience, neuroimmunology or immunology. Experience in working with primary cells or post mortem tissue is desirable.
The post is fixed term until 31st October 2025 in the first instance.
Only applications received before 12:00 midday on Wednesday 15th February 2023 will be considered.
Interviews will be held as soon as possible thereafter.